RecruitingNot applicableNCT06233526

Individualized Treatment of Pediatric R/R AML Based on Transcriptomic Profile and in Vitro Drug Sensitivity Test

Studying Inherited acute myeloid leukemia

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
The Children's Hospital of Zhejiang University School of Medicine
Principal Investigator
Xiaojun Xu, MD, MD
The Children's Hospital of Zhejiang University School of Medicine
Intervention
Chemotherapy regiments based on the transcriptomic profile and in vitro drug sensitivity test(other)
Enrollment
60 target
Eligibility
18 years · All sexes
Timeline
2024 – 2025

Study locations (1)

Collaborators

College of Pharmaceutical Science at Zhejiang University

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT06233526 on ClinicalTrials.gov

Other trials for Inherited acute myeloid leukemia

Additional recruiting or active studies for the same condition.

See all trials for Inherited acute myeloid leukemia →

← Back to all trials